Institutional
HARBOURVEST PARTNERS LLC
CIK 0001201001
$100.9M
Reported AUM
5
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · HARBOURVEST PARTNERS LLC · Q1 2026
AI · grounded in 13F
HARBOURVEST PARTNERS LLC established a new position in Generate Biomedicines GENB valued at $21.5M. The fund closed three positions, most notably exiting Rubrik, Inc. RBRK for $6.9M. Other liquidated holdings included Epsilon Energy LTD EPSN at $3.9M and Repare Therapeutics, Inc. RPTX at $31.9K.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KLAR | Klarna Group PLC | $18.62 | -0.48% | -56.62% | -50.44% | $65.8M | 65.17% | — | HELD |
| 2 | GENB | Generate Biomedicines | $13.08 | -0.46% | 3.87% | 5.12% | $21.5M | 21.33% | — | HELD |
| 3 | YMM | Full Truck Alliance Co. Ltd. | $9.64 | 3.77% | -8.69% | -37.75% | $7.9M | 7.88% | — | HELD |
| 4 | CAMP | CAMP4 Therapeutics Corp | $3.27 | -4.39% | 98.18% | -31.73% | $5.6M | 5.56% | — | HELD |
| 5 | IPSC | Century Therapeutics, Inc. | $2.02 | -1.46% | 279.70% | -91.85% | $66K | 0.06% | — | HELD |
Source: SEC EDGAR · accession 0001193125-26-225130. 13F discloses long positions only — shorts, foreign equities, and options are excluded.